Skip Header

4 results for author:"Menichincheri M." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (1)

Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists.

Schroeder G.M., Wei D., Banfi P., Cai Z.W., Lippy J., Menichincheri M., Modugno M., Naglich J., Penhallow B., Perez H.L. et al.

Bioorg. Med. Chem. Lett. 22:3951-3956(2012) · Mapped (1)

Anaplastic Lymphoma Kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy.

Ardini E., Magnaghi P., Orsini P., Galvani A., Menichincheri M.

Cancer Lett. 299:81-94(2010) · Mapped (18)

Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors.

Bossi R.T., Saccardo M.B., Ardini E., Menichincheri M., Rusconi L., Magnaghi P., Orsini P., Avanzi N., Borgia A.L., Nesi M. et al.

Biochemistry 49:6813-6825(2010) · UniProtKB (1) · Mapped (17)

First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery.

Menichincheri M., Bargiotti A., Berthelsen J., Bertrand J.A., Bossi R., Ciavolella A., Cirla A., Cristiani C., Croci V., D'Alessio R. et al.

J. Med. Chem. 52:293-307(2009) · Mapped (1)

to top of page·

Page 1 of 1